| Original language | English (US) |
|---|---|
| Pages (from-to) | 1261-1263 |
| Number of pages | 3 |
| Journal | European Journal of Heart Failure |
| Volume | 13 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2011 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Vasopressin V1 receptor-mediated aldosterone production as a result of selective V2 receptor antagonism: A potential explanation for the failure of tolvaptan to reduce cardiovascular outcomes in the EVEREST trial
Bertram Pitt*, Mihai Gheorghiade
*Corresponding author for this work
Research output: Contribution to journal › Editorial › peer-review
10
Scopus
citations